Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-307213

Chief Business Officer acquired 448 shares (grant or award)

  • Chief Business Officer gave up 148 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Robb Gary Charles · Chief Business Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-01 Grant or award : show line 1 in the form +224 $79.78 $17,871 13,834 D
2025-12-01 Grant or award : show line 2 in the form +224 14,058 D
2025-12-02 Shares withheld for taxes : show line 3 in the form −148 $79.78 $11,807 13,910 D
Loading xslF345X05/ownership.xml…